Four Essential Steps to Successful Biopharma Partnering

Successful biopharma partnerships don't occur by accident. And negotiating an out-licensing deal can be a daunting task – especially since the company may also be progressing their clinical portfolio.

In this whitepaper, Gautam Aggarwal, a partner with Triangle Insights Group provides a strategic perspective coupled with  actionable tips to help guide you through the essential steps that will help maximize your chance of achieving success in biopharma partnering.

You'll learn:

  • When partnering planning should begin 
  • How to tell if a potential deal aligns with your corporate strategy
  • How to determine the appropriate value of your product
  • Best practices for presenting to potential in-licensors
  • How to organize and present your documents for potential partners

    Indeed, the partnering or licensing process can be daunting but the process can now be simplified by focusing on the four key steps that are critical to preparing for partnering and eventually having a successful transaction.
    This white paper can help prepare you for partnerships, whether they are in the near term or far off into the future. Download your copy today!  If you'd rather watch the presentation that the white paper is based on,  click here.



ShareVault’s secure document sharing solution gives organizations of all sizes in all industries the confidence to simply and securely share sensitive documents with third parties during due diligence, fundraising, board communications, and any circumstance when it is crucial that confidential information is maintained under the highest level of security and control.

Compared to consumer-grade solutions, ShareVault virtual data rooms offer many features that give you control and document intelligence with the highest level of document-protection and monitoring available. Learn more.


Company team

Gautam Aggarwal

Partner at Triangle Insights
Group, LLC

With 13 years of pharmaceutical and
consulting experience, Gautam
focuses on providing strategic advice
to clients spanning Top-5
pharmaceutical manufacturers,
emerging biotechnology
manufacturers, bio-pharmaceutical
investors, and service providers to bio-pharmaceutical companies. Learn More